Cargando…
The Diabetic Cardiorenal Nexus
The end-stage of the clinical combination of heart failure and kidney disease has become known as cardiorenal syndrome. Adverse consequences related to diabetes, hyperlipidemia, obesity, hypertension and renal impairment on cardiovascular function, morbidity and mortality are well known. Guidelines...
Autores principales: | D’Elia, John A., Bayliss, George P., Weinrauch, Larry A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266839/ https://www.ncbi.nlm.nih.gov/pubmed/35806355 http://dx.doi.org/10.3390/ijms23137351 |
Ejemplares similares
-
Diabetic microvascular complications: possible targets for improved macrovascular outcomes
por: D’Elia, John A, et al.
Publicado: (2010) -
Sodium–glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions
por: D’Elia, John A, et al.
Publicado: (2017) -
Do biologic markers predict cardiovascular end points in diabetic end-stage renal disease? A prospective longitudinal study
por: Bayliss, George P., et al.
Publicado: (2013) -
Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review
por: D'Elia, John A., et al.
Publicado: (2016) -
Renal transplant outcomes and diabetes
por: Weinrauch, Larry A, et al.
Publicado: (2021)